Chapter I — Standard of Evidence

Formulated on evidence.
Not assumption.

Every decision behind a FINORA Nutra formulation — which ingredient, what form, what dose — traces back to published research.

Chapter II — Formulation Process

Four stages between literature and label.

  1. 01Stage 01

    Literature Review

    Every active is sourced from a documented base of peer-reviewed clinical evidence.

  2. 02Stage 02

    Dose-Matching

    Doses are set to match the clinical range that produced the effect — not rounded down for margin.

  3. 03Stage 03

    Delivery Format

    Bioavailability is engineered: chelates, phytosomes, triglyceride oils, methylated cofactors.

  4. 04Stage 04

    Advisory Review

    Every formulation passes our clinical advisory board before it enters manufacture.

Chapter III — Featured Research

Cited on the record.

Illustrative paraphrased summaries. Every FINORA formulation ships with its full reference list on the product page.

REF. 014n = 126
RCT · Double-Blind

"Randomised trial of oral magnesium glycinate over 12 weeks showed measurable improvements in subjective sleep quality and morning heart-rate variability versus placebo."

Journal of Sleep Research (paraphrased)

View Source →
REF. 027n = 4 pooled RCTs
Meta-Analysis

"Meta-analysis of nicotinamide riboside supplementation reported dose-dependent elevations in whole-blood NAD+ across adult cohorts, with a consistent safety profile at 300–1000 mg daily."

Ageing Cell (paraphrased)

View Source →
REF. 041n = 32
PK Crossover

"Comparative pharmacokinetic study of curcumin phytosome versus standardised extract demonstrated substantially higher plasma AUC in the phytosome arm."

European Journal of Nutrition (paraphrased)

View Source →
Colophon

Evidence is only half of it. Quality is the other.